logo
Select company
Select metric
$ -0.59EBITDA per Share
VS
Market
22
Sector
56
Industry
73
History
73
$ 6.45Close
$ 1.06 - $ 6.45 52-Week Range
Ticker Information

Ticker

ATAI

Company Name

ATAI LIFE SCIENCES NV

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ATAI LIFE SCIENCES NV - EBITDA per Share Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ATAI - EBITDAPS Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA per ShareShare FactorWeighted Average Shares
6/30/2025$ -115.37M$ -0.591196.56M
3/31/2025$ -144.77M$ -0.821176.27M
12/31/2024$ -145.61M$ -0.911160.16M
9/30/2024$ -124.54M$ -0.781160.62M
6/30/2024$ -53.76M$ -0.341160.39M
3/31/2024$ -29.43M$ -0.191158.89M
12/31/2023$ -35.85M$ -0.231158.83M
9/30/2023$ -58.12M$ -0.371155.79M
6/30/2023$ -137.07M$ -0.881155.79M
3/31/2023$ -141.5M$ -0.911155.79M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ATAI LIFE SCIENCES NV's latest trailing twelve months (TTM) EBITDAPS stands at $ -1.82.
  • Over the past 5 years, ATAI LIFE SCIENCES NV's average EBITDAPS has been $ -0.87.
  • The median EBITDAPS for ATAI LIFE SCIENCES NV during this period was $ -0.89
  • ATAI LIFE SCIENCES NV reached its highest EBITDAPS over the past 5 years at $ -0.19.
  • The lowest EBITDAPS recorded by ATAI LIFE SCIENCES NV in the same timeframe $ -1.82

ATAI LIFE SCIENCES NV's EBITDAPS vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDAPS Benchmarks
CompanyEBITDAPS
UPB : UPSTREAM BIO INC $ -1.93KALV : KALVISTA PHARMACEUTICALS INC $ -3.49VSTM : VERASTEM INC $ -2.47CNTB : CONNECT BIOPHARMA HOLDINGS LTD -INBX : INHIBRX BIOSCIENCES INC $ -9.91PROK : PROKIDNEY CORP $ -0.5SION : SIONNA THERAPEUTICS INC -NTRB : NUTRIBAND INC $ -0.89ORMP : ORAMED PHARMACEUTICALS INC $ -0.84TRVI : TREVI THERAPEUTICS INC $ -0.36

Definition of EBITDA per Share

[Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS
EBITDAPS for ATAI LIFE SCIENCES NV is calculated as follows: EBITDA [ $ -169.51M ] / (Shares WA [ 93.02M ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ -1.82 ]

ATAI - EBITDA per Share, Last 5 years

$ -1.82

Minimum

Dec 31, 2020

$ -0.19

Maximum

Mar 31, 2024

$ -0.87

Average

$ -0.89

Median

EBITDAPS Benchmark Analysis

The chart above depicts the distribution of EBITDAPS for companies in the Total Stock Market. The average EBITDAPS of the companies is $ 2.01 with a standard deviation of $ 4.26.
The following table provides additional summary stats:
EBITDAPS in the Market:
filtered constituents3.78K
min$ -10.86
max$ 13.95
average$ 2.01
median$ 0.99
std$ 4.26